Degradation Delivered – What the First TPD Approval Means for the Future of the Field

8:30 am - Tuesday 27th October 2026

  • Significance of the first approved targeted protein degrader
  • What the future of TPD holds beyond oncology; other targets to explore and consider
  • High-level overview of what is next for Arvinas, it’s pipeline and targets

Speakers:

President & Chief Executive Officer
Arvinas, Inc.